Migraine Prevention Drug Receives FDA Approval: Aimovig By Amgen Is The First Of Its Kind Aimovig, designed for long-term migraine prevention, will now go on sale after receiving approval from the U.S. Food and Drug Administration. The drug is the first of its kind, and it could soon mean the end of chronic migraines. by Aaron Mamiit
Health Amgen Cholesterol Drug And Statin Combo Reduces Plaque Buildup In Arteries Of Heart Patients by Rhodi Lee
Healthy Living/Wellness Drug Company Amgen Launches Online Journal For Studies That Attempt To Replicate Experimental Results by Angela Laguipo
Healthy Living/Wellness Amgen Cholesterol Drug Repatha Turned Down By UK Cost Watchdog by Rina Marie Doctor
Healthy Living/Wellness FDA Gives Approval To Amgen Melanoma Drug That Uses Herpes Virus To Fight Cancer by Katherine Derla
Healthy Living/Wellness Amgen's Virus-Based Cancer Drug Wins Green Light From EU Regulators by Ted Ranosa
Healthy Living/Wellness Express Scripts Allots 750 Million To Cover Amgen And Sanofi Cholesterol Drugs by Rina Marie Doctor
Healthy Living/Wellness Amgen Opts To Pay $71 Million For Drug Promotion Case Settlement by Rina Marie Doctor
Healthy Living/Wellness New Drug May Soon Deal With Migraines Before They Even Happen by Rina Marie Doctor
Healthy Living/Wellness FDA Panel Pushes For Approval Of Amgen's Cholesterol-Lowering Drug Repatha by Rina Marie Doctor
Healthy Living/Wellness New Drugs Can Lower Cholesterol But Price Might Give You A Big Headache - $10,000 A Year by Rhodi Lee
Healthy Living/Wellness Study Claims Amgen's Kyprolis More Effective Than Takeda's Velcade by Dianne Depra
Healthy Living/Wellness Amgen Leukemia Drug Blincyto Comes with Tag Price of $178,000 by Dianne Depra
Healthy Living/Wellness Novartis Version of Amgen Cancer Drug Just as Good as Original by Dianne Depra
Healthy Living/Wellness Amgen's brodalumab improves psoriatic arthritis signs and symptoms in Phase 2 study by Anu Passary
Healthy Living/Wellness New experimental cholesterol drug by Amgen may be better than Lipitor by Rhodi Lee
Healthy Living/Wellness Gene mutation that can reduce risk of Type 2 diabetes gets drugmakers' attention by Rhodilee Jean Dolor